reglab/housing_qa huggingface dataset:
Ohio Rev Code § 3701.145 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.145 | Director Ensure Treatment for Breast or Cervical Cancer.

Effective: September 30, 2021|Latest Legislation:  House Bill 110 - 134th General Assembly|(A) The director of health shall ensure that, as part of the Ohio breast and cervical cancer project administered under section 3701.144 of the Revised Code, a woman who meets all of the following conditions receives treatment for breast or cervical cancer: (1) The woman was screened for breast or cervical cancer by a provider who either does not participate in or was not paid for the screening by the Ohio breast and cervical cancer project. (2) The woman is in need of treatment for breast or cervical cancer. (3) The woman has a countable income not exceeding three hundred per cent of the federal poverty line. (4) The woman is not covered by health insurance. (5) The woman is less than sixty-five years of age. (B) The director of health may adopt rules as necessary to implement this section. The rules shall be adopted in accordance with Chapter 119. of the Revised Code. Last updated September 9, 2021 at 12:55 PM
Ohio Rev Code § 3701.146 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.146 | Duties and Powers Regarding Tuberculosis.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|(A) In taking actions regarding tuberculosis, the director of health has all of the following duties and powers: (1) The director shall maintain registries of hospitals, clinics, physicians, or other care providers to whom the director shall refer persons who make inquiries to the department of health regarding possible exposure to tuberculosis.(2) The director shall engage in tuberculosis surveillance activities, including the collection and analysis of epidemiological information relative to the frequency of tuberculosis infection, demographic and geographic distribution of tuberculosis cases, and trends pertaining to tuberculosis.(3) The director shall maintain a tuberculosis registry to record the incidence of tuberculosis in this state.(4) The director may appoint physicians to serve as tuberculosis consultants for geographic regions of the state specified by the director. Each tuberculosis consultant shall act in accordance with rules the director establishes and shall be responsible for advising and assisting physicians and other health care practitioners who participate in tuberculosis control activities and for reviewing medical records pertaining to the treatment provided to individuals with tuberculosis.(B)(1) The director shall adopt rules establishing standards for the following:(a) Performing tuberculosis screenings;(b) Performing examinations of individuals who have been exposed to tuberculosis and individuals who are suspected of having tuberculosis;(c) Providing treatment to individuals with tuberculosis;(d) Preventing individuals with communicable tuberculosis from infecting other individuals;(e) Performing laboratory tests for tuberculosis and studies of the resistance of tuberculosis to one or more drugs;(f) Selecting laboratories that provide in a timely fashion the results of a laboratory test for tuberculosis. The standards shall include a requirement that first consideration be given to laboratories located in this state.(2) Rules adopted pursuant to this section shall be adopted in accordance with Chapter 119. of the Revised Code and may be consistent with any recommendations or guidelines on tuberculosis issued by the United States centers for disease control and prevention or by the American thoracic society. The rules shall apply to county or district tuberculosis control units, physicians who examine and treat individuals for tuberculosis, and laboratories that perform tests for tuberculosis.
Ohio Rev Code § 3701.15 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.15 | Annual Report.

Effective: February 12, 2004|Latest Legislation:  House Bill 6 - 125th General Assembly|Each year, the director of health shall make a report to the governor, which shall include so much of the proceedings of the department of health, information concerning vital statistics and diseases, instructions on the subject of hygiene for dissemination among the people and suggestions as to legislation as the director deems proper. The director shall include in the director's annual report a full statement of all examinations made in the department's public health laboratory authorized by section 3701.22 of the Revised Code, with a detailed account of all expenses.
Ohio Rev Code § 3701.16 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.16 | Purchase, Storage, Distribution of Pharmaceutical Agents or Medical Supplies for Public Health Emergency.

Effective: February 12, 2004|Latest Legislation:  House Bill 6 - 125th General Assembly|The director of health may purchase, store, and distribute antitoxins, serums, vaccines, immunizing agents, antibiotics, and other pharmaceutical agents or medical supplies that the director deems advisable in the interest of preparing for or responding to a public health emergency. The discretion granted to the director by this section does not relieve the director of the duty to act under section 3701.161 of the Revised Code.
Ohio Rev Code § 3701.161 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.161 | Diphtheria Antitoxin.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|The director of health shall make necessary arrangements for the production and distribution of diphtheria antitoxin. Such antitoxin shall in all respects be equal in purity and potency to the standard of requirements of the United States public health service for antitoxin for interstate commerce. Diphtheria antitoxin shall be distributed in accordance with rules the director adopts pursuant to Chapter 119. of the Revised Code.
Ohio Rev Code § 3701.162 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.162 | Antitoxin for Indigent Persons.

Effective: February 12, 2004|Latest Legislation:  House Bill 6 - 125th General Assembly|Any licensed physician practicing in this state, or the superintendent of any state or county institution, may receive without charge the quantities of antitoxin as the physician or superintendent requires for the treatment or prevention of diphtheria in indigent persons, provided such antitoxin shall be used only for persons residing in the state, and that a sufficient supply is available for distribution.
Ohio Rev Code § 3701.18 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.18 | Testing Bacteria Level of Water Adjacent to Public Swimming Beaches.

Effective: September 14, 2016|Latest Legislation:  Senate Bill 293 - 131st General Assembly|The director of health shall establish techniques and procedures as appropriate for use by the division of parks and watercraft in the department of natural resources when taking samples and conducting tests under section 1546.08 of the Revised Code of the waters of this state that are adjacent to public swimming beaches as defined in that section. The director of health, in consultation with and subject to the approval of the director of natural resources, shall specify the frequency with which and location at which the waters are to be sampled and tested.The director of health shall interpret the results of the water tests conducted under section 1546.08 of the Revised Code. If the director's interpretation indicates that the bacteria levels in the waters tested present a possible health risk to persons using the waters for swimming and bathing and that the posting of signs advising the public of the condition is warranted, the director shall notify the chief of the division of parks and watercraft.
Ohio Rev Code § 3701.19 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.19 | Poison Control Network Definitions.

Effective: February 12, 2004|Latest Legislation:  House Bill 6 - 125th General Assembly|As used in sections 3701.19 to 3701.201 of the Revised Code:(A) "Poison prevention and treatment center" means an entity designated as a poison prevention and treatment center by the director of health under section 3701.20 of the Revised Code.(B) "Harm" means injury, death, or loss to person or property.(C) "Tort action" means a civil action for damages for injury, death, or loss to person or property. "Tort action" includes a product liability claim that is subject to sections 2307.71 to 2307.80 of the Revised Code, but does not include a civil action for a breach of contract or another agreement between persons.(D)(1) Subject to division (D)(2) of this section, "volunteer" means a trustee, officer, or agent of a poison prevention and treatment center, or another person associated with such a center, who satisfies both of the following:(a) Performs services for or on behalf of, and under the authority or auspices of, the center;(b) Does not receive compensation, either directly or indirectly, for performing those services.(2) For purposes of division (D)(1) of this section, "compensation" does not include any of the following:(a) Actual and necessary expenses that are incurred by a volunteer in connection with the services performed for a center, and that are reimbursed to the volunteer or otherwise paid;(b) Insurance premiums paid on behalf of a volunteer, and amounts paid or reimbursed, pursuant to division (E) of section 1702.12 of the Revised Code;(c) Modest perquisites.
Ohio Rev Code § 3701.201 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.201 | Rules for Reporting Bioterrorism, Epidemic or Pandemic Disease, Infectious Agents, Toxins Posing Risk of Human Fatality or Disability.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|(A) As used in this section, "bioterrorism" has the same meaning as in section 3701.232 of the Revised Code. (B) The director of health shall adopt rules in accordance with Chapter 119. of the Revised Code under which a poison prevention and treatment center or other health-related entity is required to report events that may be caused by bioterrorism, epidemic or pandemic disease, or established or novel infectious agents or biological or chemical toxins posing a risk of human fatality or disability. Rules adopted under this section may require a report of any of the following:(1) An unexpected pattern or increase in the number of telephone inquiries or requests to provide information about poison prevention and treatment and available services;(2) An unexpected pattern or increase in the number of requests to provide specialized treatment, consultation, information, and educational programs to health care professionals and the public;(3) An unexpected pattern or increase in the number of requests for information on established or novel infectious agents or biological or chemical toxins posing a risk of human fatality or disability that is relatively uncommon and may have been caused by bioterrorism.(C) Each poison prevention and treatment center and other health-related entity shall comply with any reporting requirement established in rules adopted under division (B) of this section.(D) Information reported under this section that is protected health information pursuant to section 3701.17 of the Revised Code shall be released only in accordance with that section. Information that does not identify an individual may be released in summary, statistical, or aggregate form.
Ohio Rev Code § 3701.21 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.21 | Save Our Sight Fund.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|(A) As used in this section: (1) "Amblyopia" means reduced vision in an eye that has not received adequate use during early childhood.(2) "501(c) organization" means an organization exempt from federal income taxation pursuant to 26 U.S.C.A. 501(a) and (c).(B) There is hereby created in the state treasury the save our sight fund. The fund shall consist of voluntary contributions deposited as provided in section 4503.104 of the Revised Code. All investment earnings from the fund shall be credited to the fund.(C) The director of health shall use the money in the save our sight fund as follows:(1) To provide support to 501(c) organizations that offer vision services in all counties of the state and have demonstrated experience in the delivery of vision services to do one or more of the following:(a) Implement a voluntary children's vision screening training and certification program for volunteers, child care providers, nurses, teachers, health care professionals practicing in primary care settings, and others serving children;(b) Provide materials for the program implemented under division (C)(1)(a) of this section;(c) Develop and implement a registry and targeted voluntary case management system to determine whether children with amblyopia are receiving professional eye care and to provide their parents with information and support regarding their child's vision care;(d) Establish a matching grant program for the purchase and distribution of protective eyewear to children;(e) Provide vision health and safety programs and materials for classrooms.(2) For the purpose of section 4503.104 of the Revised Code, to develop and distribute informational materials on the importance of eye care and safety to the registrar of motor vehicles and each deputy registrar;(3) To pay costs incurred by the director in administering the fund;(4) To reimburse the bureau of motor vehicles for the administrative costs incurred in performing its duties under section 4503.104 of the Revised Code.(D) A 501(c) organization seeking funding from the save our sight fund for any of the projects specified in division (C) of this section shall submit a request for the funding to the director in accordance with rules adopted under division (E) of this section. The director shall determine the appropriateness of and approve or disapprove projects for funding and approve or disapprove the disbursement of money from the save our sight fund.(E) The director shall adopt rules in accordance with Chapter 119. of the Revised Code to implement this section. The rules shall include the parameters of the projects specified in division (C)(1) of this section that may be funded with money in the save our sight fund and procedures for 501(c) organizations to request funding from the fund.
Ohio Rev Code § 3701.22 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.22 | Public Health Laboratory.

Effective: February 12, 2004|Latest Legislation:  House Bill 6 - 125th General Assembly|The department of health shall maintain a public health laboratory for the following:(A) Examination of public water supplies and the effluent of sewage purification works;(B) Diagnosis of, screening for, or confirmation of diseases or pathogens as it deems necessary;(C) Performance of biological, chemical, or radiological analyses or examinations as it deems necessary;(D) Analysis of patient specimens and food samples necessary for investigation of foodborne illnesses. In foodborne illness investigations, the laboratory shall cooperate and consult with the director of agriculture acting pursuant to section 3715.02 of the Revised Code.
Ohio Rev Code § 3701.221 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.221 | Chemical and Bacteriological Laboratory.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|(A) The director of health shall have charge of the public health laboratory authorized by section 3701.22 of the Revised Code. The director may employ an assistant for the laboratory who shall be a person skilled in chemistry and bacteriology, and receive compensation as the director determines. All expenses of the laboratory shall be paid from appropriations made for the department of health. (B) The director, in accordance with Chapter 119. of the Revised Code, shall adopt, and may amend or rescind, rules establishing reasonable fees for services the laboratory performs. The director need not prescribe fees where the director believes that charging fees would significantly and adversely affect the public health. All fees collected for services the laboratory performs shall be deposited into the state treasury to the credit of the laboratory handling fee fund, which is hereby created for the purpose of defraying expenses of operating the laboratory.
Ohio Rev Code § 3701.23 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.23 | Reporting Contagious or Infectious Diseases, Illnesses, Health Conditions, or Unusual Infectious Agents or Biological Toxins.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|(A) As used in this section, "health care provider" means any person or government entity that provides health care services to individuals. "Health care provider" includes, but is not limited to, hospitals, medical clinics and offices, special care facilities, medical laboratories, physicians, pharmacists, dentists, physician assistants, registered and licensed practical nurses, laboratory technicians, emergency medical service organization personnel, and ambulance service organization personnel. (B) Boards of health, health authorities or officials, health care providers in localities in which there are no health authorities or officials, and coroners or medical examiners shall report promptly to the department of health the existence of any of the following:(1) Asiatic cholera;(2) Yellow fever;(3) Diphtheria;(4) Typhus or typhoid fever;(5) As specified by the director of health, other contagious or infectious diseases, illnesses, health conditions, or unusual infectious agents or biological toxins posing a risk of human fatality or disability.(C) No person shall fail to comply with the reporting requirements established under division (B) of this section.(D) The reports required by this section shall be submitted on forms, as required by statute or rule, and in the manner the director of health prescribes.(E) Information reported under this section that is protected health information pursuant to section 3701.17 of the Revised Code shall be released only in accordance with that section. Information that does not identify an individual may be released in summary, statistical, or aggregate form.
Ohio Rev Code § 3701.231 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.231 | Laboratory Compliance With Reporting and Confidentiality Requirements.

Effective: February 12, 2004|Latest Legislation:  House Bill 6 - 125th General Assembly|If a medical laboratory outside this state performs a test or other diagnostic or investigative analysis that results in information pertaining to a resident of this state that must be reported under section 3701.23 or 3707.06 of the Revised Code, the entity using the laboratory shall ensure that the laboratory complies with reporting and confidentiality requirements and shall verify to the director of health that the laboratory complies with reporting and confidentiality requirements. The director shall establish procedures by which an entity may verify the laboratory's compliance.
Ohio Rev Code § 3701.232 (2021)
2021 Ohio Revised Code|Title 37 | Health-Safety-Morals|Chapter 3701 | Department of Health|Section 3701.232 | Reporting Significant Changes in Medication Usage That May Be Caused by Bioterrorism, Epidemic or Pandemic Disease.

Effective: September 10, 2012|Latest Legislation:  House Bill 487 - 129th General Assembly|(A) As used in this section: (1) "Bioterrorism" means the intentional use of any microorganism, virus, infectious substance, or biological product that may be engineered as a result of biotechnology, or any naturally occurring or bioengineered component of a microorganism, virus, infectious substance, or biological product, to cause death, disease, or other biological malfunction in a human, animal, plant, or other living organism as a means of influencing the conduct of government or intimidating or coercing a population.(2) "Pharmacist" means an individual licensed under Chapter 4729. of the Revised Code to engage in the practice of pharmacy as a pharmacist.(3) "Pharmacy" and "prescription" have the same meanings as in section 4729.01 of the Revised Code.(B) The director of health shall adopt rules in accordance with Chapter 119. of the Revised Code under which a pharmacy or pharmacist is required to report significant changes in medication usage that may be caused by bioterrorism, epidemic or pandemic disease, or established or novel infectious agents or biological toxins posing a risk of human fatality or disability. Rules adopted under this section may require a report of any of the following:(1) An unexpected increase in the number of prescriptions for antibiotics;(2) An unexpected increase in the number of prescriptions for medication to treat fever or respiratory or gastrointestinal complaints;(3) An unexpected increase in sales of, or the number of requests for information on, over-the-counter medication to treat fever or respiratory or gastrointestinal complaints;(4) Any prescription for medication used to treat a disease that is relatively uncommon and may have been caused by bioterrorism.(C) No person shall fail to comply with any reporting requirement established in rules adopted under division (B) of this section.(D) Information reported under this section that is protected health information pursuant to section 3701.17 of the Revised Code shall be released only in accordance with that section. Information that does not identify an individual may be released in summary, statistical, or aggregate form.